STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

Press releases published on July 6, 2026

3 hours ago

Cloudastructure Strengthens Balance Sheet with Elimination of Variable Conversion Debt Feature and Provides Update on First Quarter 2026 Filing

Indeterminate GlobeNewswire

3 hours ago

SalesCloser Technologies to Commence Trading on the OTCQB Venture Market

Indeterminate GlobeNewswire

3 hours ago

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

Indeterminate GlobeNewswire

3 hours ago

Bilan semestriel du Contrat de Liquidité de DBV Technologies avec ODDO BHF

Indeterminate GlobeNewswire

3 hours ago

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

4 hours ago

SEALSQ Corp Reports Preliminary H1 2026 Results; Revenue up 120%, FY 2026 Guidance Reaffirmed

Indeterminate GlobeNewswire

4 hours ago

Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

4 hours ago

Abivax Announces Closing of $920 Million Public Offering

Indeterminate GlobeNewswire

4 hours ago

Abivax annonce la réalisation de son offre au public de 920 millions de dollars

Indeterminate GlobeNewswire

4 hours ago

Sprout Social to Announce Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

4 hours ago

Longeveron® Appoints Marie Washburn as Chief Financial Officer

Indeterminate GlobeNewswire

4 hours ago

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

4 hours ago

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

Indeterminate GlobeNewswire

4 hours ago

Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection

Indeterminate GlobeNewswire

4 hours ago

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

4 hours ago

Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering

Indeterminate GlobeNewswire

4 hours ago

Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine

Indeterminate GlobeNewswire

5 hours ago

Alberta Cancer Foundation invests $35-million to power cancer clinical trials for Albertans

Indeterminate GlobeNewswire

5 hours ago

VivoPower Targets Up To USD$4 million Incremental Annualized EBITDA from Battery Energy Storage Integration at Norway Data Center

Indeterminate GlobeNewswire

5 hours ago

Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases

Indeterminate GlobeNewswire